Possibilities and prospects of using biofluorescent proteins at the stage of preclinical evaluation of live vaccines, using the example of the Yersinia pestis vaccine strain EV NIIEG pTURBOGFP-B - PDF (英语)
版权所有 © Klyueva S.N., Budanova A.A., Kravtsov A.L., Bugorkova S.A., 2025

此作品已接受知识共享署名 4.0国际许可协议的许可